Table 1 Demographics and clinical characteristics
Characteristics | HAP group (n = 38) | Control group (n = 46) | P-value |
|---|---|---|---|
Age | 89.01±5.83 | 88.03±4.20 | 0.379 |
CPIS score | 8.45±1.69 | 2.50±1.44 | < 0.001 |
Comorbidities, n (%) | |||
COPD | 11 (29) | 12 (26) | n.s. |
Diabetes mellitus type 2 | 10 (26) | 10 (22) | n.s. |
Heart failure | 8 (21) | 9 (20) | n.s. |
Hypertension | 13 (34) | 17 (37) | n.s. |
Chronic renal disease | 6 (16) | 5 (11) | n.s. |
Solid tumor malignancy | 4 (11) | 5 (11) | n.s. |
28-day mortality, n (%) | 13.0 (34.2) | 3.0 (6.5) | 0.018 |